动脉粥样硬化研究：缘起、观点及发展趋势
Atherosclerosis Research: Origin, Viewpoint and Development Trend
DOI: 10.12677/ACM.2022.125716, PDF,  被引量   
作者: 李 晨：青海大学附属医院老年医学，青海 西宁；李 蓉*：青海大学附属医院全科医学，青海 西宁；李 立：咸阳市第一人民医院神经内科，陕西 咸阳
关键词: 动脉粥样硬化学说；研究进展；Atherosclerosis Theory； Research Progress
摘要: 动脉粥样硬化作为一个重要的心血管疾病研究领域，世界医学界已对其进行了大量的探索和研究。期间因科技技术的局限性，对其认识停滞，甚至遭遇坎坷，但近些年伴随研究规模的快速发展，关于AS的研究成果也令人瞩目。本文通过搜索国内知网、万方，国外Pubmed等大型搜索网站有关动脉粥样硬化研究历史背景、观点及最新研究进展等相关文献资料，并进行整理汇总，梳理国内外研究，总结动脉粥样硬化最新研究进展，重点结合最新相关研究成果，希望能理清动脉粥样硬化各研究学说之间联系，为将来动脉粥样硬化研究方向提出一些建设性意见。
Abstract: Atherosclerosis, as an important field of cardiovascular disease research, has been explored and studied by the world medical community for hundreds of years. During this period, due to the limi-tations of scientific and technological technology, the understanding of it is stagnant and even bumpy, but in recent years, with the rapid development of research scale, the research results on AS are also remarkable. In this paper, by searching the historical background, viewpoint and latest research progress of atherosclerosis research on large search websites such as domestic knowledge network, Wanfang and foreign Pubmed, and sorting out and summarizing the domestic and foreign research, summarizing the latest research progress of atherosclerosis, focusing on combining the latest relevant research results, hoping to sort out the relationship between the research theories of atherosclerosis and put forward some constructive opinions for the future research direction of atherosclerosis.
文章引用：李晨, 李蓉, 李立. 动脉粥样硬化研究：缘起、观点及发展趋势[J]. 临床医学进展, 2022, 12(5): 4934-4950. https://doi.org/10.12677/ACM.2022.125716

参考文献

[1] 杨永宗, 刘录山. 中国动脉粥样硬化纪事(十二) [J]. 中国动脉硬化杂志, 2016, 24(12): 1292-1296.
[2] Ali, M., Girgis, S., Hassan, A., et al. (2018) Inflammation and Coronary Artery Disease: From Pathophysiology to Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS). Coronary Artery Disease, 29, 429-437. [Google Scholar] [CrossRef] 
[3] Raman, P. and Khanal, S. (2021) Leptin in Atherosclerosis: Focus on Macrophages, Endothelial and Smooth Muscle Cells. International Journal of Molecular Sciences, 22, 5446. [Google Scholar] [CrossRef] [PubMed]
[4] Naryzhnaya, N.V., Koshelskaya, O.A., Kologrivova, I.V., et al. (2021) Hypertrophy and Insulin Resistance of Epicardial Adipose Tissue Adipocytes: Association with the Coronary Artery Disease Severity. Biomedicines, 9, 64. [Google Scholar] [CrossRef] [PubMed]
[5] Christensen, R.H., Wedell-Neergaard, A.S., Lehrskov, L.L., et al. (2019) Effect of Aerobic and Resistance Exercise on Cardiac Adipose Tissues: Secondary Analyses from a Random-ized Clinical Trial. JAMA Cardiology, 4, 778-787. [Google Scholar] [CrossRef] [PubMed]
[6] Galvez, R., Portano, J., Cortes, R.T., et al. (2020) Reduction of Epicardial Adipose Tissue Thickness with PCSK9 Inhibitors. European Heart Journal, 41, ehaa946.3008. [Google Scholar] [CrossRef] 
[7] Parisi, V., Petraglia, L., D’Esposito, V., et al. (2019) Statin Thera-py Modulates Thickness and Inflammatory Profile of Human Epicardial Adipose Tissue. International Journal of Cardi-ology, 274, 326-330. [Google Scholar] [CrossRef] [PubMed]
[8] Ziyrek, M., Kahraman, S., Ozdemir, E., et al. (2019) Metformin Monotherapy Significantly Decreases Epicardial Adipose Tissue Thickness in Newly Diagnosed Type 2 Diabetes Pa-tients. Revista Portuguesa de Cardiologia, 38, 419-423. [Google Scholar] [CrossRef] [PubMed]
[9] Salim, H.M., Fukuda, D., Higashikuni, Y., et al. (2017) Ten-eligliptin, a Dipeptidyl Peptidase-4 Inhibitor, Attenuated Pro-Inflammatory Phenotype of Perivascular Adipose Tissue and Inhibited Atherogenesis in Normoglycemic Apolipoprotein-E-Deficient Mice. Vascular Pharmacology, 96-98, 19-25. [Google Scholar] [CrossRef] [PubMed]
[10] Nogueira, J.P. (2021) Effect of SGLT2-Inhibitors on Epi-cardial Adipose Tissue: A Meta-Analysis. Cells, 10, 2150. [Google Scholar] [CrossRef] [PubMed]
[11] Tsjoa, B., Atlfc, D., Avb, A., et al. (2021) Colchicine in Patients with Chronic Coronary Disease in Relation to Prior Acute Coronary Syndrome. Journal of the American College of Cardiol-ogy, 78, 859-866. [Google Scholar] [CrossRef] [PubMed]
[12] Allen, N., Barrett, T.J., Guo, Y., et al. (2019) Circulating Mono-cyte-Platelet Aggregates Are a Robust Marker of Platelet Activity in Cardiovascular Disease. Atherosclerosis, 282, 11-18. [Google Scholar] [CrossRef] [PubMed]
[13] Marchio, P., Guerra-Ojeda, S., Vila, J.M., et al. (2019) Targeting Early Atherosclerosis: A Focus on Oxidative Stress and Inflammation. Oxidative Medicine and Cellular Lon-gevity, 2019, Article ID: 8563845. [Google Scholar] [CrossRef] [PubMed]
[14] Kuravi, S.J., Harrison, P., Rainger, G.E., et al. (2019) Ability of Plate-let-Derived Extracellular Vesicles to Promote Neutrophil-Endothelial Cell Interactions. Inflammation, 42, 290-305. [Google Scholar] [CrossRef] [PubMed]
[15] Hartley, B.A., Fmedsci, D. and Rkmc, F. (2019) Oxidized LDL and Anti-Oxidized LDL Antibodies in Atherosclerosis—Novel Insights and Future Directions in Diagnosis and Therapy. Trends in Cardiovascular Medicine, 29, 22-26. [Google Scholar] [CrossRef] [PubMed]
[16] Morton, A.M., Koch, M., Mendivil, C.O., et al. (2018) Apolipo-proteins E and CIII Interact to Regulate HDL Metabolism and Coronary Heart Disease Risk. JCI Insight, 3, e98045. [Google Scholar] [CrossRef] [PubMed]
[17] Lu, Y., Cui, X., Zhang, L., et al. (2022) The Functional Role of Lip-oproteins in Atherosclerosis: Novel Directions for Diagnosis and Targeting Therapy. Aging and Disease, 13, 491-520.
[18] Shu, H., Peng, Y., Hang, W., et al. (2022) Emerging Roles of Ceramide in Cardiovascular Diseases. Ag-ing and Disease, 13, 232-245. [Google Scholar] [CrossRef] 
[19] Amirfakhryan, H. (2020) Vaccination against Atherosclerosis: An Overview. Hellenic Journal of Cardiology, 61, 78-91. [Google Scholar] [CrossRef] [PubMed]
[20] Higashi, Y., Noma, K., Yoshizumi, M., et al. (2009) Endothelial Function and Oxidative Stress in Cardiovascular Diseases. Circulation Journal, 73, 411-418. [Google Scholar] [CrossRef] 
[21] 蒋琬姿, 张丽雯, 贺彩红, 阮梅花, 季勇, 于建荣, 等. 家族性高胆固醇血症研究进展[J]. 遗传, 2021, 43(11): 1011-1040.
[22] Chen, L., Zhou, Z., Hu, C., et al. (2022) Platelet Mem-brane-Coated Nanocarriers Targeting Plaques to Deliver Anti-CD47 Antibody for Atherosclerotic Therapy. Research, 2022, Article ID: 9845459. [Google Scholar] [CrossRef] [PubMed]
[23] Yin, J., Xia, W., Wu, M., et al. (2019) Inhibition of Mitochondrial Complex I Activity Attenuates Neointimal Hyperplasia by Inhibiting Smooth Muscle Cell Proliferation and Migration. Chemico-Biological Interactions, 304, 73-82. [Google Scholar] [CrossRef] [PubMed]
[24] Zullo, A., Guida, R., Sciarrillo, R., et al. (2022) Redox Homeostasis in Cardiovascular Disease: The Role of Mitochondrial Sirtuins. Frontiers in Endocrinology, 13, Article ID: 858330. [Google Scholar] [CrossRef] [PubMed]
[25] Razeghian-Jahromi, I., Karimi, A.A., Razmkhah, M., et al. (2022) Immune System and Atherosclerosis: Hostile or Friendly Relationship. International Journal of Immunopathology and Pharmacology, 36, Article ID: 1190312284. [Google Scholar] [CrossRef] [PubMed]
[26] Yoo, J.Y., Sniffen, S., McGill, P.K., et al. (2022) Gut Dysbiosis and Immune System in Atherosclerotic Cardiovascular Disease (ACVD). Microorganisms, 10, Article No. 108. [Google Scholar] [CrossRef] [PubMed]
[27] He, L., Zhang, C.L., Chen, Q., et al. (2022) Endothelial Shear Stress Signal Transduction and Atherogenesis: From Mechanisms to Therapeutics. Pharmacology & Therapeutics, 235, Article ID: 108152. [Google Scholar] [CrossRef] [PubMed]
[28] Tao, J., Cao, X., Yu, B., et al. (2022) Vascular Stem/Progenitor Cells in Vessel Injury and Repair. Frontiers in Cardiovascular Medicine, 9, Article ID: 845070. [Google Scholar] [CrossRef] [PubMed]
[29] Guieu, R., Ruf, J. and Mottola, G. (2022) Hyperhomocysteinemia and Cardiovascular Diseases. Annales de Biologie Clinique, 80, 7-14. [Google Scholar] [CrossRef] [PubMed]
[30] Dai, Y., Chen, D. and Xu, T. (2022) DNA Methylation Aberrant in Atherosclerosis. Frontiers in Pharmacology, 13, Article ID: 815977. [Google Scholar] [CrossRef] [PubMed]
[31] 浦冬青, 刘政, 周超, 梁佳玮, 郝清智. 近10年动脉粥样硬化发病机制研究热点的可视化分析[J]. 世界科学技术-中医药现代化, 2021, 23(7): 2276-2284.
[32] Yu, N., Wang, R., Liu, B., et al. (2022) Bibliometric and Visual Analysis on Metabolomics in Coronary Artery Disease Research. Fron-tiers in Cardiovascular Medicine, 9, Article ID: 804463. [Google Scholar] [CrossRef] [PubMed]

为你推荐